Cargando…
Inhibition of the Striatal Specific Phosphodiesterase PDE10A Ameliorates Striatal and Cortical Pathology in R6/2 Mouse Model of Huntington's Disease
BACKGROUND: Huntington's disease is a devastating neurodegenerative condition for which there is no therapy to slow disease progression. The particular vulnerability of striatal medium spiny neurons to Huntington's pathology is hypothesized to result from transcriptional dysregulation with...
Autores principales: | Giampà, Carmela, Laurenti, Daunia, Anzilotti, Serenella, Bernardi, Giorgio, Menniti, Frank S., Fusco, Francesca Romana |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2955524/ https://www.ncbi.nlm.nih.gov/pubmed/20976216 http://dx.doi.org/10.1371/journal.pone.0013417 |
Ejemplares similares
-
Cortical and Striatal Circuits in Huntington’s Disease
por: Blumenstock, Sonja, et al.
Publicado: (2020) -
Conditioned medium from amniotic cells protects striatal degeneration and ameliorates motor deficits in the R6/2 mouse model of Huntington's disease
por: Giampà, Carmela, et al.
Publicado: (2018) -
Selective Sparing of Striatal Interneurons after Poly (ADP-Ribose) Polymerase 1 Inhibition in the R6/2 Mouse Model of Huntington’s Disease
por: Paldino, Emanuela, et al.
Publicado: (2017) -
Huntington’s Disease and Striatal Signaling
por: Roze, Emmanuel, et al.
Publicado: (2011) -
Dual tasking impairments are associated with striatal pathology in Huntington’s disease
por: Lo, Johnny, et al.
Publicado: (2020)